INTRODUCTION
A cardiopulmonary exercise test (CPET) is considered the 'gold-standard' method for evaluating aerobic fitness [maximal oxygen uptake (V̇O 2max )] in patients with mild-tomoderate cystic fibrosis (CF). The European CF Society (ECFS) Exercise Working Group recently promoted CPET as the exercise testing method of choice for this patient group.
Moreover, the ECFS Clinical Trials Network Standardisation Committee has called for assessment of the validity, reproducibility and feasibility of outcome measures utilised in CF and advocated research into the most appropriate exercise test for paediatric patients [1] .
Recently, our research group presented a combined incremental and supramaximal (S max ) verification CPET protocol, which is superior at determining valid V̇O 2max in young CF patients compared to a ramp only protocol [2] . V̇O 2max is currently the principle outcome from a CPET, as it has been shown to be an independent predictor of CF patient mortality [3] .
However, a more comprehensive evaluation of patients' cardiorespiratory fitness may be gained from CPET, through the quantification of submaximal parameters of aerobic (lactate threshold (LT), the kinetics of V̇O 2 and work efficiency) and ventilatory (V̇E/V̇CO 2 -slope and oxygen uptake efficiency slope (OUES) [4] ) function. Submaximal outcomes may be especially useful in the clinical environment, as patients may not be able or willing to provide a maximal effort.
Unfortunately, insufficient data exists regarding the reproducibility of CPET in CF patients and that which does exist has utilised testing protocols which cannot verify a 'true' maximal effort[e.g. 5, 6] . Moreover, the only paediatric study to address this issue [5] did not measure V̇O 2max . Quantifying reproducibility enables researchers and clinicians to understand the variation associated with outcome measures [7] and to determine meaningful changes [8] .
Consequently, inferences regarding therapeutic interventions or disease-related changes in CPET derived parameters cannot currently be discerned with certainty in these patients. Therefore, this study sought to establish the short-(48 h) and medium-term (4-6 weeks) reproducibility of maximal and submaximal indicators of cardiorespiratory fitness using our recently validated CPET protocol. Submaximal gas exchange parameters. The LT was non-invasively identified using the gas exchange threshold (GET) [11] and confirmed through visual inspection of the ventilatory equivalents for V̇O 2 and V̇CO 2 [12] . The V̇O 2 mean response time (MRT) was determined using the time from the onset of the ramp test to the intersection point between the baseline V̇O 2 and a backwards extrapolation of the slope of V̇O 2 as a function of time. The V̇O 2 'gain' (ΔV̇O 2 /Δ WR) was determined by regression of the 'linear' portion of the V̇O 2 response against power output. The OUES for the entire exercise duration (OUES 100 ) and up to the GET (OUES GET )
MATERIAL and METHODS

Study population. Thirteen young patients (
were derived from the slope of the linear function between V̇O 2 (mL•min -1 ) and log V̇E (L•min -1 ) [4] . The V̇E/V̇CO 2 -slope (ventilatory drive) was calculated using linear regression during the entire CPET [13] .
Additional measures: Heart rate (HR) was determined every 5-s (PhysioFlow, PF-05, Manatec Biomedical, Paris, France), with the highest 15-s value taken as peak HR (HR peak ).
Fingertip arterial O 2 saturation (SpO 2% ) was measured on a beat-by-beat basis via pulse oximetry (NONIN, Avant 4000, NONIN Medical Inc., USA). Subjective ratings of perceived exertion (RPE) and dyspnoea (RPD) were recorded upon exhaustion using the pictorial children's effort rating table (P-CERT) and the 0-10 category ratio (CR-10) scale, respectively, the methodology for which is described elsewhere [2] .
Analysis. Data are expressed as means and standard deviations unless otherwise stated.
Reproducibility was assessed using a downloadable spreadsheet [14] . Following initial analyses to ensure distribution normality and heteroscedasticity, paired samples t-tests examined differences between tests with significance set at p < 0.05. Change in the mean, intraclass correlation coefficients (ICCs), absolute typical error (TE) and TE expressed as a percentage of the coefficient of variation (TE CV% ), were calculated (with 90% confidence limits) for short-(T 1 -T 2 ) and medium-term (T 1 -T 3 ) pairwise comparisons.
RESULTS
One patient was lost to follow-up at T 3 , due to reasons unrelated to the study. Maximal and submaximal physiological responses from the CPET are presented in Table 2 . Short-(T 1 -T 2 ) and medium-term (T 1 -T 3 ) reproducibility data from CPET derived measures are presented in Tables 3 and 4 respectively. The reproducibility for V̇O 2max is presented in Figure 1 . The GET and OUES GET were identifiable in all patients at T 1 and 12
(92%) patients at T 2 and T 3 . MRT was detected in 11 (85%) patients from T 1 -T 3 .
When compared with this combined approach (ramp and S max ), V̇O 2max obtained using the traditional ramp only method was significantly lower at both 
DISCUSSION
The principle finding of this study was that CPET was reproducible when determining observed for all measures, highlighting the potential for CPET outcomes to be used to monitor disease progression and/or the effect of therapeutic interventions.
Our data contribute significantly to the literature because the reproducibility of V̇O 2max
has not been established in CF using a valid protocol. Reproducibility over time is crucial when evaluating the efficacy of treatments (e.g. antimicrobials, mucolytics and gene mutation targeted therapies) which may accrue over weeks or months, as well as monitoring exercise training interventions (4-6 weeks). To our knowledge, only one study has examined the reproducibility of S max verified (treadmill) V̇O 2peak in a paediatric clinical population [15] , reporting an 8.2% (100 mL) variation in young spina bifida patients over a 2 week period.
Using a solitary traditional ramp test, variations of 6.9% [6] and 8.5% [16] have been reported over 4 weeks in CF adults for V̇O 2peak . The reproducibility estimate for V̇O 2max in the present study is therefore similar (9.3% and 13.3%) to these earlier studies [6, 16] and confirms CPET as a reproducible assessment tool. Whilst the compromised validity of performing traditional ramp tests, such as the popular Gofrey protocol, in isolation has previously been demonstrated [2] and substantiated herein, the present study in paediatric CF patients also highlights a larger within-subject variation in V̇O 2max over both the short-(13.5 vs. 9.3 %) and medium-term (15.5 vs. 13.3 %) when compared with the combined ramp and S max approach.
Only one study [5] has previously investigated CPET reproducibility in CF children, but is limited due to methodological concerns. Firstly, only three outcome measures (peak power output, SaO 2% and HR) were obtained, offering limited interpretation of aerobic fitness.
Moreover, an intermittent sprint cycle test preceded the ramp test, which likely caused fatigue and may explain, in part, their low ramp test duration (~4 min).
Outcome measures which can assess patients' ability to perform at intensities similar to activities of daily living are also important. Submaximal measures hold specific value when maximal exercise performance is limited by ventilatory capacity and/or effort [2, 4] . week period [16] . Similar variations of 7.8% and 17.7% were documented for the V̇E/V̇CO 2 -slope in the present study. As the OUES GET was associated with increased short-(17.9%) and medium-term (45.4%) error and lower detection rate compared to the OUES 100 , the OUES 100 appears a more robust outcome measure.
The present study provides the reproducibility for maximal and submaximal parameters over the short-and medium-term. Our data denote that V̇O 2max changes exceeding 9% (150 mL) and 13% (160 mL) may indicate a change attributable to therapeutic intervention or disease progression over the short-and medium-term, respectively. The TE must, however, be considered relative to an established smallest worthwhile change (SWC), to estimate how many participants are needed to observe a 'meaningful' effect [7, 8, 24] .
Using Hopkins' formula [7] However, the mean annual rate of V̇O 2max decline could, for example, be used to determine the SWC in V̇O 2max , since it reportedly predicts CF patient survival [29] . Using Pianosi and colleagues' [29] annual V̇O 2max decline and the fitness of our similarly aged patients, a ~6% increase in V̇O 2max relative to baseline fitness would be required to prevent a meaningful drop in prognostic stratification. Using 6% as the SWC and a 13.3% TE, 5 patients would be required to detect a change in V̇O 2max from a 4-6 week intervention that would be considered meaningful and clinically worthwhile.
Determining the extent to which changes in outcome measurements relate to a given reference measure is essential to the clinical utility of CPET. Responsiveness to intervention has been conceptually described as a signal-to-noise ratio [7, 8, 24] , whereby the TE represents the 'noise' and any intervention-induced effect, the 'signal'. In conclusion, V̇O 2max was reproducible over 48-h (Δ150 mL; Δ9.3%) and 4-6 wks (Δ160 mL; Δ13.3%). Supplementary maximal and submaximal parameters should be incorporated to comprehensively assess aerobic function. The present study provides a reproducible CPET protocol for young patients with mild-to-moderate CF and will inform sample size and power calculations when planning interventional studies that use cardiorespiratory fitness as an endpoint.
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